ויפנד 200 מ"ג אבקה להזרקה
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
VORICONAZOLE 200 MG/VIAL
Available from:
PFIZER PHARMACEUTICALS ISRAEL LTD
ATC code:
J02AC03
Pharmaceutical form:
POWDER FOR SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
PFIZER PGM, FRANCE
Therapeutic group:
VORICONAZOLE
Therapeutic indications:
Treatment of : - invasive aspergillosis fluconazole-resistant serious invasive Candida infections (including C. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. Treatment of candidemia in non neutropenic patients.
Authorization date:
2012-10-01
